Author
University of California, Los AngelesORCID 0009-0001-0776-3217Unclaimed ORCID profile · follow to get notified of new preprints
Mutual co-authors in cluster
3 papers
Recent·Most cited
Jiangyue Liu, Iveta Fajnorovà, Yuwei Ren…·Saul J. Priceman
Combining 177Lu-PSMA-617 radioligand therapy with PSCA-CAR T cells improves tumor control and survival in prostate cancer models by overcoming antigen heterogeneity and reshaping the immunosuppressive tumor microenvironment.
Rebecca L. Brouillette, Frédérique Lussier, Émile Breault…·Philippe Sarret
This paper describes a pepducin derived from NTS1 that acts as a biased allosteric modulator, preferentially activating G proteins over β-arrestin and inhibiting receptor internalization.
Élora Midavaine, Rebecca L. Brouillette, Élizabeth Théberge…·Philippe Sarret
The paper shows that CCR2-targeting pepducin PP101 reduces bone cancer pain by inhibiting T cell infiltration and neuroimmune communication in dorsal root ganglia without adverse effects.